Northstar pares ops; homes in on depression
This article was originally published in Clinica
Executive Summary
Neuromodulation technology company Northstar Neuroscience said it has decided to put its stroke clinical programme on hold and instead, channel its efforts exclusively on its treatment-resistant depression (TRD) research.